Tone mix
Week by week 51 weeks
Share of Zevra Therapeutics, Inc. Common Stock's 139 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Jul 21, 2025 · tone -100Zevra Therapeutics (NASDAQ:ZVRA) Stock Rating Lowered by Wall Street Zen-117
- Week of Jul 27, 2026 · tone -88Zevra Therapeutics, Inc. (ZVRA) Securities Fraud Investigation - Levi ...-115
- Week of May 12, 2025 · tone +100Zevra Therapeutics (ZVRA) Stock Jumps on Strong Q1 Results: What's Going On? - Zevra Therapeutics (NASDAQ:ZVRA)+85
- Week of Jul 28, 2025 · tone +88Zevra Therapeutics Submits Marketing Authorization Application to European Medicines Agency to Review Arimoclomol for the Treatment of Niemann-Pick Disease Type C+68
- Week of May 26, 2025 · tone +100Citizens JMP Reiterates Buy Rating on Zevra Therapeutics (ZVRA), Keeps PT+63
- Week of Jun 8, 2026 · tone +83Zevra Therapeutics extends MIPLYFFA exclusivity to 2041+52
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Zevra Therapeutics, Inc. Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 4 | +25 |
| Last 30 sessions | 8 | +12 |
| Last 90 sessions | 30 | +1 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Thursday, November 5, 2026
2 headlines, average tone +50: 1 positive, 1 neutral and 0 negative. Showing all 2.
- www.rttnews.com · 1 outletZevra Therapeutics Q3 Revenue Rises 45% To $37.8 Mln As MIPLYFFA Sales Grow; Stock UpPositive
- www.fool.com · 1 outletZevra (ZVRA) Q3 2026 Earnings Call TranscriptNeutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Zevra Therapeutics Q3 Revenue Rises 45% To $37.8 Mln As MIPLYFFA Sales Grow; Stock Up | www.rttnews.com | 1 | Positive |
| Zevra (ZVRA) Q3 2026 Earnings Call Transcript | www.fool.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, November 4, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletZevra Therapeutics (NASDAQ:ZVRA) Releases Quarterly Earnings ResultsNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Zevra Therapeutics (NASDAQ:ZVRA) Releases Quarterly Earnings Results | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, November 2, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletIndivior (NASDAQ:INDV) & Zevra Therapeutics (NASDAQ:ZVRA) Financial ReviewNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Indivior (NASDAQ:INDV) & Zevra Therapeutics (NASDAQ:ZVRA) Financial Review | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 23, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.dailypolitical.com · 1 outletFinancial Comparison: Zevra Therapeutics (NASDAQ:ZVRA) vs. Clene (NASDAQ:CLNN)Neutral
- www.tickerreport.com · 1 outletContrasting Clene (NASDAQ:CLNN) and Zevra Therapeutics (NASDAQ:ZVRA)Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Financial Comparison: Zevra Therapeutics (NASDAQ:ZVRA) vs. Clene (NASDAQ:CLNN) | www.dailypolitical.com | 1 | Neutral |
| Contrasting Clene (NASDAQ:CLNN) and Zevra Therapeutics (NASDAQ:ZVRA) | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 2, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.tickerreport.com · 1 outletReviewing Zevra Therapeutics (NASDAQ:ZVRA) & Vireo Growth (OTCMKTS:VREOD)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Reviewing Zevra Therapeutics (NASDAQ:ZVRA) & Vireo Growth (OTCMKTS:VREOD) | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Zevra Therapeutics, Inc. Common Stock, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.